From: Prolonged and intensive medication use are associated with the obesity paradox after percutaneous coronary intervention: a systematic review and meta-analysis of 12 studies
Discharged and follow-up Medications
Normal weight patients
Overweight patients
Obese patients
Aspirin (%)
94.7
95.1
95.0
Clopidogrel (%)
82.4
83.1
83.2
Statin (%)
76.8
79.3
81.3
ACEI/ARBs (%)
55.8
65.2
68.8
Beta blocker (%)
70.4
72.1
73.8